These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 4629348)

  • 21. [The importance of unusual isoimmunizations in the prophylaxis of hemolytic disease of the newborn].
    Joó-Szabados T; Neubauer G; Székessy V; Wohlmuth G
    Acta Paediatr Acad Sci Hung; 1970; 11(2):111-4. PubMed ID: 5504582
    [No Abstract]   [Full Text] [Related]  

  • 22. Automation in the blood transfusion laboratory: I. Antibody dectection and quantitation in the technicon autoanalyzer.
    Moore BP
    Can Med Assoc J; 1969 Feb; 100(8):381-7. PubMed ID: 4974689
    [No Abstract]   [Full Text] [Related]  

  • 23. [Late mortality of children subjected to exchange transfusion at birth].
    Baratono S; Grazia G; Nicola P
    Minerva Pediatr; 1972 Mar; 24(9):347-57. PubMed ID: 4622768
    [No Abstract]   [Full Text] [Related]  

  • 24. [The importance to the newborn infant of determining the Rh antibodies of the mother's milk. (Review of the literature)].
    Umbrumiants DV
    Vopr Okhr Materin Det; 1966 Jan; 11(1):58-61. PubMed ID: 4964739
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-ce (anti-f) in a CDe-cD-mother, as a cause of haemolytic disease of the newborn.
    Spielmann W; Seidl S; von Pawel J
    Vox Sang; 1974; 27(5):473-7. PubMed ID: 4213590
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in umbilical-cord blood oxygen affinity after intrauterine transfusions for erythroblastosis.
    Novy MJ; Frigoletto FD; Easterday CL; Umansky I; Nelson NM
    N Engl J Med; 1971 Sep; 285(11):589-95. PubMed ID: 5563959
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemoglobin level and erythrocyte count in children up to 2 years old treated by exchange transfusions because of blood incompatibility].
    Rudkowski Z; Prandota A; Czarnecka M; Bohdanowicz E
    Pediatr Pol; 1969 Dec; 44(12):1487-93. PubMed ID: 4984229
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fetal hemoglobin in the blood of the umbilical veins in newborn infants with Rh-incompatibility].
    Neumayer E; Retzke U
    Zentralbl Gynakol; 1970 Aug; 92(34):1118-20. PubMed ID: 4995980
    [No Abstract]   [Full Text] [Related]  

  • 29. HL-A antibodies: influence on the human foetus.
    Ahrons S
    Tissue Antigens; 1971; 1(3):129-36. PubMed ID: 5005219
    [No Abstract]   [Full Text] [Related]  

  • 30. An assessment of intra-uterine foetal tranfusion.
    Connon AF; Hay JA; Kneebone GM; Jones GH; Stentiford HB
    Med J Aust; 1967 Jul; 2(3):93-7. PubMed ID: 4961911
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of fetal hemolytic disease using plasmapheresis].
    Schwarzlos G; During R; Müller S; Stark KH; Plesse R
    Zentralbl Gynakol; 1989; 111(24):1599-603. PubMed ID: 2624011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 34. [Organization of the early diagnosis of hemolytic disease of the newborn at the District Institute for Blood Banking in Leipzig].
    Thierbach V; Berge H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):353-8. PubMed ID: 4193013
    [No Abstract]   [Full Text] [Related]  

  • 35. The epidemiology of severe haemolytic disease of the newborn.
    Kinnock S; Liley AW
    N Z Med J; 1970 Feb; 71(453):76-83. PubMed ID: 4986220
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prenatal determination of the fetal blood group].
    Meroni P; Della Torre L
    Ann Ostet Ginecol Med Perinat; 1969 Jul; 91(7):497-507. PubMed ID: 4997558
    [No Abstract]   [Full Text] [Related]  

  • 38. Rh-D isoimmunization in a triplet pregnancy.
    Desjardins PD; Dodds JR; Willoughby HW
    Can Med Assoc J; 1972 May; 106(9):1000-1. PubMed ID: 4623745
    [No Abstract]   [Full Text] [Related]  

  • 39. A management programme for Rh alloimmunization during pregnancy.
    Filbey D; Berseus O; Lindeberg S; Wesström G
    Early Hum Dev; 1987 Jan; 15(1):11-20. PubMed ID: 3102210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress in the diagnosis, therapy and prevention of morbus hemolyticum neonatorum].
    Kintzel HW
    Z Arztl Fortbild (Jena); 1968 Jun; 62(12):634-40. PubMed ID: 4971390
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.